million, respectively, as a result of marketing events couple with the increase in operating expense due to the expenses of new outlets. The company focuses on the sustainable growth, thus, set up a

, Samutsakhon 74000 No. DOD43/2563 May 14, 2020 To: The President The Stock Exchange of Thailand (SET) Subject: Management’s Discussion and Analysis for the first Quarter of 2020 DOD Biotech Public Company

losses on inventories devaluation [NRV] THB 1,689 million] . And, due to the state of the price of crude oil declining significantly, the company recorded loss on impairments in assets under the

companies under the market capital of THB 30,000 - 100,000 million from SET Awards 2019, organised by the Stock Exchange of Thailand and Money and Banking Magazine. Furthermore, the company remains listed to

administrative expense was increased from the same period of the year 2019 in an amounting of Baht 5.27 million or 19.21 percent. Due to the Company change the concept to set up Management’s discussion and

, primarily due to gain from fair value adjustment of investment property at THB 794m realized in 2Q18. The Company made the first dividend payment which was made from 2018 Net profit at THB 0.04 per share on

-year average of 68.0 percent. Consequently, employment contracted by 0.7 percent. Private consumption slightly softened due to stagnant farm and non-farm income growth. Moreover, household debt, which

)236-835 150/18 Mitraparb Rd. Muang Khon Kaen Thailand 40000 Tel. (043) 333-555 Fax. (043)236-835 Ratchaphruek Hospital No. RPH-SET 8/20178 May 10, 2018 Subject : Management Discussion and Analysis

gross profit for the year 2019, an increase of Baht 18.60 million compared to the previous year from increased revenue and cost management by carefully set up own operational and maintenance for machines

Page 1 Date 25 February 2020 Re: Management Discussion & Analysis for the Year Ended 31 December 20020 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN PUBLIC COMPANY